Dare Bioscience (DARE) Receivables - Other (2017 - 2025)
Dare Bioscience (DARE) has disclosed Receivables - Other for 7 consecutive years, with $369157.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other fell 28.86% year-over-year to $369157.0, compared with a TTM value of $369157.0 through Sep 2025, down 28.86%, and an annual FY2024 reading of $229982.0, down 75.77% over the prior year.
- Receivables - Other was $369157.0 for Q3 2025 at Dare Bioscience, up from $188116.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $3.0 million in Q2 2021 and bottomed at $105234.0 in Q1 2025.
- Average Receivables - Other over 5 years is $1.1 million, with a median of $949211.0 recorded in 2023.
- The sharpest move saw Receivables - Other skyrocketed 1568.48% in 2021, then tumbled 92.41% in 2025.
- Year by year, Receivables - Other stood at $1.1 million in 2021, then soared by 48.71% to $1.7 million in 2022, then plummeted by 44.27% to $949211.0 in 2023, then tumbled by 75.77% to $229982.0 in 2024, then surged by 60.52% to $369157.0 in 2025.
- Business Quant data shows Receivables - Other for DARE at $369157.0 in Q3 2025, $188116.0 in Q2 2025, and $105234.0 in Q1 2025.